Drugs / adrenocorticotropic hormone
adrenocorticotropic hormone
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01155141 | Sep 2009 → Jan 2014 | kidney disorder | Stanford University | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | adrenocorticotropic hormone | “Treatment of idiopathic FSGS with adrenocorticotropic hormone gel.” PMID 24009220 ↗ Sep 2013 |
| Known as | ACTH | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01155141 ↗ |
| Known as | ACTH gel | “treated with ACTH gel at two academic medical centers” PMID 24009220 ↗ Sep 2013 |
| Known as | H.P. Acthar Gel | “ACTH therapy (H.P. Acthar Gel) can provide a more rapid, well tolerated reduction in glomerular injury.” NCT01155141 ↗ |